ask="6.96"
ask_size="1000"
average_daily_volume="35557"
bid="6.01"
bid_size="100"
book_value="1.99"
change="-0.25"
change_from_200_day_moving_average="-0.90"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-4.23"
change_From_52_week_low="0.68"
change_in_percent="-3.90%"
close="6.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.87"
ebitda="-10.01M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8645000"
high="6.49"
high_52_weeks="10.51"
last_trade_date="1/12/2017"
last_trade_price="6.28"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.10"
low_52_weeks="5.60"
market_capitalization="83.30M"
moving_average_200_day="7.18"
moving_average_50_day="6.24"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.00"
open="6.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.58%"
percent_change_from_50_day_moving_average="+0.66%"
percent_change_from_52_week_high="-40.25%"
percent_change_from_52_week_low="+12.14%"
previous_close="6.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.29"
price_per_sales="135.23"
revenue="640999.00"
shares_outstanding="13264000"
short_ratio="6.22"
stock_exchange="NCM"
symbol="ORMP"
volume="27047"
weeks_range_52="5.60 - 10.51"
